GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

bamlanivimab   Click here for help

GtoPdb Ligand ID: 11325

Synonyms: LY-3819253 | LY-CoV555 | LY3819253
Compound class: Antibody
Comment: Bamlanivimab is a monoclonal antibody against the surface spike protein of SARS-CoV-2. It was developed by Eli Lilly, but such is the speed of COVID-19 therapeutic development, there are no peer-reviewed articles that report its design, preclinical or early clinical data.
Classification Click here for help
Compound class Antibody
Withdrawn drug? Yes
International Nonproprietary Names Click here for help
INN number INN
11876 bamlanivimab
Synonyms Click here for help
LY-3819253 | LY-CoV555 | LY3819253
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1104
Other databases
GtoPdb PubChem SID 434321760
Search PubMed clinical trials bamlanivimab
Search PubMed titles bamlanivimab
Search PubMed titles/abstracts bamlanivimab